Stereotaxis completes acquisition of Robocath
Stereotaxis has announced that it has completed its previously announced acquisition of Robocath—an innovator of robotic technologies for interventional cardiology and neurointerventions.
As per a press...
J&J announces US FDA approval for dual-energy ThermoCool SmartTouch SF platform
Johnson & Johnson (J&J) has announced that the US Food and Drug Administration (FDA) has approved the dual-energy ThermoCool SmartTouch SF platform (DE STSF)—an...
AtaCor announces first patient treated globally in ALARION-EV pivotal trial
AtaCor Medical announced today the enrolment of the first patient in the company's ALARION-EV study, which is evaluating an investigational, next-generation parasternal extravascular implantable...
Global experts update heart failure definition to improve prevention, diagnosis and care
A new international expert consensus document has attempted to refine how heart failure is identified and classified, aiming to improve prevention, diagnosis and management of the...
